Skip to Content

Pinnacle I.N. (Canada)

This page contains information on Pinnacle I.N. for veterinary use.
The information provided typically includes the following:
  • Pinnacle I.N. Indications
  • Warnings and cautions for Pinnacle I.N.
  • Direction and dosage information for Pinnacle I.N.

Pinnacle I.N.

This treatment applies to the following species:
Manufacturer: Zoetis

Streptococcus Equi Vaccine

Live Culture

FOR INTRANASAL USE ONLY.

DO NOT ADMINISTER BY ANY ROUTE OTHER THAN INTRANASAL.

This product has been shown to be effective for the vaccination of healthy horses 9 months of age or older against Streptococcus equi. Duration of immunity has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

Directions For Use

Aseptically rehydrate with the entire contents of the accompanying sterile diluent. Instill the entire rehydrated vaccine into one nostril using a syringe with applicator tip. Administer a second dose 2 to 3 weeks later. Historically, annual revaccination with this product was recommended. The need for annual booster vaccinations has not been established; consultation with a veterinarian or the manufacturer is recommended.

This product contains live bacteria and is designed for intranasal use only. Disinfect hands and

equipment after use. Contamination of the user’s hands or equipment with reconstituted vaccine could lead to infections if proper disinfection practices are not followed prior to procedures that require asepsis. Injection equipment used to reconstitute or administer Pinnacle I.N. should not be reused, and should be disposed of appropriately.

Precautions

In case of anaphylactoid reaction, administer epinephrine. After administration, a small number of horses may experience non-contagious transitory upper respiratory signs including transient, non-contagious nasal discharge from 1 day to 3 weeks post vaccination. A small number of horses may experience abscess and/or lymphadenopathy within 1-7 weeks post-vaccination. In very rare cases the vaccine strain may be the cause. Fever may also be noted after vaccination. Purpura hemorrhagica may be seen in hypersensitive individuals following exposure to streptococcal proteins. Store in the dark at 2°C to 8°C. Do not freeze. Shake well after rehydration. Do not vaccinate within 30 days before slaughter. Use entire contents when first opened. Inactivate unused contents before disposal. This product has not been tested in pregnant animals. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician.

Technical inquiries should be directed to Zoetis Inc. Veterinary Services, (800) 461-0917.

For Veterinary Use Only

U.S. Vet. License No. 190

Zoetis Inc., Kalamazoo, MI 49007, USA

10 DOSES

10 - 2.5 mL Vials of Vaccine
plus 10 - 2.5 mL Vials of Diluent

40025079

CPN: 1198396.3

ZOETIS CANADA INC.
16,740 TRANS-CANADA HIGHWAY, KIRKLAND, QC, H9H 4M7
Order Desk:   800-663-8888
Technical Services Canada:   800-461-0917
Technical Services USA:   800-366-5288
Website:   www.zoetis.ca
Every effort has been made to ensure the accuracy of the Pinnacle I.N. information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2019 Animalytix LLC. Updated: 2018-11-30

Hide